Company intelligence / Profile preview

IfitMed Healthcare

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

IfitMed Healthcare is a Shanghai-based biotechnology company specializing in the development of precision diagnostic solutions for early cancer detection. The company leverages a proprietary DNA methylation detection platform to identify specific epigenetic markers associated with various malignancies. Their primary focus includes the development of non-invasive screening tests for gynecological cancers, such as cervical and endometrial cancer, as well as other solid tumors. By integrating advanced molecular biology with bioinformatics, IfitMed aims to provide highly sensitive and specific diagnostic tools to improve patient outcomes through early intervention.

Therapeutic areas: Oncology
Modalities: Molecular diagnosticsDiagnostic test
Industry: Molecular Diagnostics

Partnerships

Fudan University

Beyond the preview

Go deeper on IfitMed Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IfitMed Healthcare.

Explore the full profile